Sartorius AG Xetra

SRT

DE0007165607

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 11:35:20 2024-04-16 am EDT			After market 12:47:41 pm
258.5 ^EUR	-1.34%		258	-0.19%

Apr. 09	Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	MT
Apr. 09	Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	MT

SARTORIUS VORZUEGE : Hauck & Aufhauser Upgrades to Neutral

July 09, 2020 at 03:23 am EDT

Hauck & Aufhauser is out with its report today upgrading SARTORIUS VORZUEGE from Sell to Neutral. The target price is revised upwards from EUR 320 to EUR 135.

Latest news about Sartorius AG

Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	Apr. 09	MT
Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	Apr. 09	MT
SARTORIUS VORZUEGE : Barclays reaffirms its Neutral rating	Mar. 28	ZD
Transcript : Sartorius Aktiengesellschaft - Shareholder/Analyst Call	Mar. 28
SARTORIUS VORZUEGE : JP Morgan maintains a Buy rating	Mar. 28	ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral	Mar. 27	ZD
Stifel reinstates Sartorius with 'Buy' - target 415 euros	Mar. 18	DP
SARTORIUS VORZUEGE : UBS reiterates its Neutral rating	Mar. 14	ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral	Mar. 12	ZD
Jefferies raises target for Sartorius to 359 euros - 'Hold'	Mar. 12	DP
SARTORIUS VORZUEGE : Barclays remains Neutral	Feb. 22	ZD
Sartorius falls - outlook from Repligen disappointed	Feb. 21	DP
Warburg Research raises target for Sartorius to 320 euros - 'Hold'	Feb. 19	DP
SARTORIUS VORZUEGE : Warburg Research remains Neutral	Feb. 19	ZD
Deutsche Bank Research lowers target for Sartorius - 'Hold'	Feb. 16	DP
Sartorius Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
SARTORIUS VORZUEGE : Deutsche Bank reaffirms its Neutral rating	Feb. 16	ZD
Berenberg raises target for Sartorius to 346 euros - 'Buy'	Feb. 16	DP
SARTORIUS VORZUEGE : Berenberg gives a Buy rating	Feb. 16	ZD
Sartorius gains despite halving dividend	Feb. 09	DP
Sartorius Board Proposes Lower FY23 Dividend	Feb. 09	MT
Sartorius to halve dividend	Feb. 09	DP
SARTORIUS VORZUEGE : Barclays reaffirms its Neutral rating	Feb. 07	ZD
SARTORIUS VORZUEGE : Warburg Research remains Neutral	Feb. 07	ZD
SARTORIUS VORZUEGE : Jefferies reiterates its Neutral rating	Feb. 07	ZD

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-18 - Q1 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SARTORIUS : FY23: Updated mid-term outlook offers much valued ‘certainty’

January 29, 2024 at 09:04 am EST

More Strategies

Ratings for Sartorius AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

342.4 EUR

Average target price

352.3 EUR

Spread / Average Target

+2.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-45.32%	2.77B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+7.25%	1.7B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-7.99%	1.53B
BIOTAGE AB	+27.37%	1.27B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-13.75%	991M
CONTEC MEDICAL SYSTEMS CO.,LTD	-23.36%	878M
REVENIO GROUP OYJ	-4.79%	742M
VAREX IMAGING CORPORATION	-15.32%	707M
CELLAVISION AB	+4.48%	476M

Medical Diagnostic & Testing Equipment

Sartorius AG Xetra

Equities

SRT

DE0007165607

Advanced Medical Equipment & Technology

SARTORIUS VORZUEGE : Hauck & Aufhauser Upgrades to Neutral

Latest news about Sartorius AG

Chart Sartorius AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Sartorius AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment